Moderna Inc
Pharmaceutical & Health Products · Lobbying Client
Moderna Inc's Federal Lobbying Record
Moderna Inc's $9.2M in disclosed federal lobbying puts it in the mid-tier of registered filers. Spending in the seven-figure range is common for established trade groups, mid-size corporations, and advocacy organizations that maintain a steady but not aggressive presence on Capitol Hill.
Across the 5-year window from 2020 to 2024, Moderna Inc's annual disclosed lobbying spend has held roughly steady — $2.0M at the start versus $2.1M at the most recent year-end. Year-to-year wobbles inside that range usually reflect timing of legislative cycles rather than a strategic shift.
Moderna Inc's disclosed lobbying focuses on a narrow 4-issue footprint. A focused issue list usually means the organization concentrates its federal engagement on a small set of bills or rulemakings directly relevant to its core business.
2 of 6 lobbyists reported by Moderna Inc (33%) disclose prior federal government service. That share is common at established government affairs operations that explicitly hire from agency and committee staff.
Among the named bench, lobbyists with disclosed prior federal service include Robert L. Walker (Former Special Assistant, National Security Council); Steven F. Martin (Former Special Assistant, National Security Council). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Moderna Inc ranks #19 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Moderna Inc's $9.2M sits 45% below the sector average.
Moderna Inc's LobbySpend Influence Score of 54/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Moderna Inc's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Cornerstone Government Affairs | MEDGOVPHA | 2 | $611K |
| 2024 Jul-Sep | Subject Matter | MEDHCRPHA | 4 | $472K |
| 2024 Apr-Jun | Fierce Government Relations | PHAHCR | 4 | $516K |
| 2024 Jan-Mar | Peck Madigan Jones | GOVMED | 2 | $486K |
| 2023 Oct-Dec | DLA Piper | GOVPHA | 3 | $377K |
| 2023 Jul-Sep | Peck Madigan Jones | PHAMEDGOV+1 | 1 | $469K |
| 2023 Apr-Jun | Peck Madigan Jones | MEDHCRGOV+1 | 2 | $380K |
| 2023 Jan-Mar | Squire Patton Boggs | PHAHCR | 4 | $343K |
Moderna Inc Lobbying FAQ
Moderna Inc has spent $9.2M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.
Moderna Inc lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.
Moderna Inc has an Influence Score of 54/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Moderna Inc employs 6 registered lobbyists, of whom 2 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Moderna Inc has contacted 5 government entities as part of their lobbying activities, including Dept of Homeland Security, Dept of Commerce, Dept of Energy.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.